azomycin has been researched along with riboflavin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bae, YM; Bair, TB; Choi, KP; Daniels, L | 1 |
Choi, KP; Daniels, L; Kendrick, N | 1 |
Nathan, C | 1 |
Barry, CE; Boshoff, HI; Dowd, CS; Ha, YH; Jiricek, J; Kang, S; Keller, TH; Kim, P; Ledwidge, R; Lee, IY; Manjunatha, U; Niyomrattanakit, P; Singh, R; Zhang, L | 1 |
Mukhopadhyay, B; Purwantini, E | 1 |
Fujiwara, M; Hariguchi, N; Kawasaki, M; Liu, Y; Matsumoto, M | 1 |
Loganathan, U; Mukhopadhyay, B; Purwantini, E | 1 |
7 other study(ies) available for azomycin and riboflavin
Article | Year |
---|---|
Use of transposon Tn5367 mutagenesis and a nitroimidazopyran-based selection system to demonstrate a requirement for fbiA and fbiB in coenzyme F(420) biosynthesis by Mycobacterium bovis BCG.
Topics: Antitubercular Agents; Bacterial Proteins; Coenzymes; DNA Transposable Elements; Drug Resistance, Bacterial; Enzymes; Genes, Bacterial; Genetic Complementation Test; Multigene Family; Mutagenesis, Insertional; Mycobacterium bovis; Nitroimidazoles; Operon; Riboflavin; Sequence Analysis, DNA; Transcription, Genetic | 2001 |
Demonstration that fbiC is required by Mycobacterium bovis BCG for coenzyme F(420) and FO biosynthesis.
Topics: Cloning, Molecular; DNA Transposable Elements; Escherichia coli; Genes, Bacterial; Genetic Complementation Test; Histidine; Molecular Sequence Data; Multigene Family; Mutagenesis, Insertional; Mycobacterium bovis; Nitroimidazoles; Riboflavin | 2002 |
Microbiology. An antibiotic mimics immunity.
Topics: Anaerobiosis; Antitubercular Agents; Glucosephosphate Dehydrogenase; Humans; Mycobacterium tuberculosis; Nitric Oxide; Nitroimidazoles; Nitroreductases; Reactive Nitrogen Species; Riboflavin; Tuberculosis | 2008 |
PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release.
Topics: Anaerobiosis; Antitubercular Agents; Glucosephosphate Dehydrogenase; Immunity, Innate; Mycobacterium tuberculosis; Nitric Oxide; Nitric Oxide Donors; Nitroimidazoles; Nitroreductases; Oxidation-Reduction; Prodrugs; Reactive Nitrogen Species; Riboflavin; Stereoisomerism | 2008 |
Rv0132c of Mycobacterium tuberculosis encodes a coenzyme F420-dependent hydroxymycolic acid dehydrogenase.
Topics: Amino Acid Sequence; Antitubercular Agents; Bacterial Proteins; Cell Wall; Gene Expression; Humans; Kinetics; Molecular Sequence Data; Mycobacterium tuberculosis; Mycolic Acids; Nitroimidazoles; Oxidoreductases; Riboflavin; Sequence Alignment; Sequence Homology, Amino Acid; Substrate Specificity | 2013 |
Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Chromatography, High Pressure Liquid; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Genotype; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium bovis; Mycobacterium tuberculosis; Nitroimidazoles; Nitroreductases; Oxazoles; Phenotype; Riboflavin | 2018 |
Coenzyme F
Topics: Antitubercular Agents; Bacterial Proteins; Drug Resistance, Bacterial; Glucosephosphate Dehydrogenase; Ligases; Methanobacteriaceae; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Polyglutamic Acid; Recombinant Proteins; Riboflavin; Tetrahydrofolates | 2018 |